The next post will be an article written by a Medical Pathologist, Dr. Ed Freidlander. The below statement is at the end of the article. Apparently, Dr. Moro may not be interested in an independent review.
"Follow-up (August 31, 2008): Despite their expressed eagerness to have independent review, the promoters have not responded to my e-mails"
Just as a note, when searching for anything related to RECAF, 99.99% of the stuff that comes up is about the stock or released by BioCurex and not about the product. I have also read warnings about products if similar types of hits occur, it is an obvious sign that the product is almost totally unknown to anyone outside of investment circles. The article I found is one of the exceptions and is about the product.